We think Amgen's going to be an important participant in this global health crisis. Amgen joins an increasingly competitive field: Eli Lilly recently saw its chronic weight product, injectable ZepBound (tirzepatide), approved by the FDA, while Novo Nordisk already has two weight-loss peptides on the market, Saxenda (liraglutide) and Wegovy (semaglutide)
Well clarify your goals (e.g., energy, appetite control, joint comfort, body composition), review your history, and recommend a stepwise plan often beginning with lifestyle foundations , then layering medications or peptides as needed
Immunohistochemical analysis has revealed GLP-1 R expression in the acinar and ductal epithelium of the lacrimal gland, although this expression is significantly downregulated in diabetic models
Although GLP-1 medications help reduce hunger and cravings, the best results occur when treatment is combined with healthy eating, regular physical activity, and positive lifestyle habits
In all the trials, TZP outperformed its comparators in HbA1c outcomes (reductions), diabetes reductions, WL, and risk of adverse cardiovascular events